1-119925511-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024408.4(NOTCH2):c.4305G>A(p.Arg1435Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,614,144 control chromosomes in the GnomAD database, including 1,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 111 hom., cov: 32)
Exomes 𝑓: 0.012 ( 1063 hom. )
Consequence
NOTCH2
NM_024408.4 synonymous
NM_024408.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.569
Publications
4 publications found
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
- acroosteolysis dominant typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Alagille syndrome due to a NOTCH2 point mutationInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Alagille syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-119925511-C-T is Benign according to our data. Variant chr1-119925511-C-T is described in ClinVar as Benign. ClinVar VariationId is 195907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.569 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0987 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0156 AC: 2370AN: 152138Hom.: 112 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2370
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0342 AC: 8604AN: 251302 AF XY: 0.0348 show subpopulations
GnomAD2 exomes
AF:
AC:
8604
AN:
251302
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0119 AC: 17395AN: 1461888Hom.: 1063 Cov.: 33 AF XY: 0.0142 AC XY: 10338AN XY: 727246 show subpopulations
GnomAD4 exome
AF:
AC:
17395
AN:
1461888
Hom.:
Cov.:
33
AF XY:
AC XY:
10338
AN XY:
727246
show subpopulations
African (AFR)
AF:
AC:
62
AN:
33480
American (AMR)
AF:
AC:
5715
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
216
AN:
26136
East Asian (EAS)
AF:
AC:
57
AN:
39700
South Asian (SAS)
AF:
AC:
9194
AN:
86258
European-Finnish (FIN)
AF:
AC:
658
AN:
53414
Middle Eastern (MID)
AF:
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
682
AN:
1112012
Other (OTH)
AF:
AC:
791
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1446
2891
4337
5782
7228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0156 AC: 2370AN: 152256Hom.: 111 Cov.: 32 AF XY: 0.0200 AC XY: 1488AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
2370
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
1488
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
112
AN:
41540
American (AMR)
AF:
AC:
1433
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
29
AN:
3472
East Asian (EAS)
AF:
AC:
18
AN:
5180
South Asian (SAS)
AF:
AC:
512
AN:
4814
European-Finnish (FIN)
AF:
AC:
150
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
76
AN:
68024
Other (OTH)
AF:
AC:
40
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
111
221
332
442
553
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
194
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Mar 11, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hajdu-Cheney syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.